How a synthetic lipoprotein targets tumor metabolism to trigger cancer cell death

Northwestern Medicine scientists have developed a promising approach to killing treatment-resistant cancer cells by exploiting their hidden metabolic vulnerabilities, according to a study published in the Proceedings of the National Academy of Sciences.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup